A New Drug Deal: Kremer Makes Case for Vaccines in Newsweek Interview

Harvard Professor Michael Kremer, a non-resident fellow at CGD, makes the case for an advance market commitment for vaccines for developing countries in an interview in the current issue of Newsweek. Kremer is a co-author of the CGD report Making Markets for Vaccines: Ideas to Action.

From the Interview:

Are there any precedents for your approach? Yes, in the U.K. in 1994 there was an outbreak of a bacterial infection causing brain swelling. The government said that if a treatment were produced, they’d buy it. It was, they did, and cases of infection went down by 90 percent.